Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for EVHO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2010. Start Trial.
Date Value
June 30, 2026 0.0219M
March 31, 2026 -0.0108M
December 31, 2025 0.044M
September 30, 2025 0.006M
June 30, 2025 0.0008M
March 31, 2025 0.0017M
September 30, 2024 0.00
June 30, 2024 0.1132M
March 31, 2024 0.8185M
December 31, 2023 -0.0528M
September 30, 2023 -0.2922M
June 30, 2023 0.3903M
March 31, 2023 0.2524M
December 31, 2022 0.1214M
September 30, 2022 0.8126M
June 30, 2022 0.6623M
March 31, 2022 0.2836M
December 31, 2021 0.088M
September 30, 2021 1.281M
June 30, 2021 0.4928M
March 31, 2021 1.658M
December 31, 2020 0.5928M
September 30, 2020 0.2498M
June 30, 2020 0.4055M
March 31, 2020 0.2644M
Date Value
December 31, 2019 0.4469M
September 30, 2019 0.397M
June 30, 2019 0.2076M
March 31, 2019 0.3557M
December 31, 2018 0.2918M
September 30, 2018 0.035M
June 30, 2018 0.0575M
March 31, 2018 0.092M
December 31, 2017 -0.1374M
September 30, 2017 0.0524M
June 30, 2017 0.075M
March 31, 2017 0.1325M
December 31, 2016 0.0361M
September 30, 2016 0.0454M
June 30, 2016 0.0316M
March 31, 2016 0.0559M
December 31, 2015 0.026M
September 30, 2015 0.0164M
June 30, 2015 0.0164M
March 31, 2015 0.1652M
December 31, 2014
September 30, 2014 0.0019M
June 30, 2014
March 31, 2014
December 31, 2013

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
BioForce Nanosciences Holdings, Inc. 0.0209M
DND Technologies, Inc. --
Skinhealth Systems, Inc. -0.224M
Bonk, Inc. -0.10M
Upexi, Inc. 7.686M